In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Your browser does not support iframes. Our coverage area is an unusual geographic market: the Lehigh Valley and Berks County. It's the third largest business district ...

For immediate concerns about closed captioning of broadcast programs or online video content during weekday business hours 8 a.m.-5 p.m., call David Harpe at (303) 830-6426 or e-mail ...